| 1 |
[GO] |
2023―Nov―20 |
ANTIVIRAL ACTIVITY OF ORIGINAL FLAVONOIDS-CONTAINING PHYTOPREPARATION AGAINST HUMAN ALPHAHERPESVIRUS 2, HEPATITIS C SURROGATE VIRUS AND TRANSMISSIBLE GASTROENTERITIS CORONAVIRUS |
ALEXANDER GALKIN |
| 2 |
[GO] |
2023―Jul―20 |
THE EFFICACY OF ANTIDEPRESIVE TREATMENT ON COVID-19 PANDEMIC-RELATED DEPRESSIVE SYMPTOMS - A PROSPECTIVE, SINGLE-CENTER, QUESTIONNAIRE-BASED STUDY |
ANDREEA SĂLCUDEAN |
| 3 |
[GO] |
2023―Jul―20 |
PERCEPTIONS OF FRONTLINE HEALTHCARE PROFESSIONALS ON COVID-19 VACCINATION |
RALUCA ELISABETA LUPAȘCU MOISI |
| 4 |
[GO] |
2023―Mar―16 |
THE EVOLUTION AND TREATMENT OPTIONS OF PATIENTS WITH COVID-19 AND NEUROLOGICAL MANIFESTATIONS - A NARRATIVE REVIEW |
IRINA ODAJIU |
| 5 |
[GO] |
2023―Mar―16 |
EVALUATION OF KNOWLEDGE ON THE PREVENTIVE PRACTICE OF COVID-19 AMONG MIDDLE-AGED ADULTS IN SAUDI ARABIA - A CROSS-SECTIONAL QUESTIONNAIRE BASED STUDY |
MAHMOOD BASIL A. AL-RAWI |
| 6 |
[GO] |
2023―Mar―16 |
STUDY ON THE INCIDENCE AND PROFILE OF RISK FACTORS IN THE FIELD OF HEALTHCARE PRACTICE IN PHARMACEUTICAL CARE DURING THE COVID-19 PANDEMIC PERIOD |
CLAUDIA-CAMELIA BURCEA |
| 7 |
[GO] |
2023―Mar―16 |
THE COVID-19 PANDEMIC′S IMPACT ON HEALTHCARE PROFESSIONALS′ MENTAL HEALTH |
MATEI PALIMARICIUC |
| 8 |
[GO] |
2023―Mar―16 |
THE IMPACT OF INFLAMMATION AND DRUG INTERACTIONS ON COVID-19 PHARMACOTHERAPY. A MINI-REVIEW |
MONICA NEAMȚU |
| 9 |
[GO] |
2022―Jul―14 |
THE EVALUATION OF VITAMIN D DEFICIENCY AS A RISK FACTOR IN THE CASE OF PATIENTS WITH MODERATE COVID-19 |
LAURA-CORINA NICOLESCU |
| 10 |
[GO] |
2022―Jul―14 |
CHALLENGES REGARDING THE INTERACTION BETWEEN PSYCHOTROPICS AND COVID-19 CO-MEDICATION |
CĂTĂLINA-ANGELA CRIȘAN |
| 11 |
[GO] |
2022―Jul―14 |
ARTEMISIA SPECIES AND ARTEMISININ DERIVATIVES AS ANTIVIRAL AGENTS AGAINST COVID-19. CURRENT KNOWLEDGE: CHEMISTRY, PHARMACOLOGY AND CLINICAL EVIDENCE |
MOHAMMAD HUDAIB |
| 12 |
[GO] |
2022―Jul―14 |
LATE-ONSET EPILEPSY IN THE ELDERLY: DIFFICULTIES OF DIAGNOSIS AND PERSONALIZED PHARMACOLOGICAL MANAGEMENT, WITH PARTICULARITIES TO COVID-19 PANDEMIC - SYSTEMATIC REVIEW OF LITERATURE |
AURELIAN ANGHELESCU |
| 13 |
[GO] |
2022―Jul―14 |
KNOWLEDGE AND ATTITUDE OF PHARMACY STUDENTS TOWARDS COVID-19 PANDEMIC AND ITS IMPACT ON THEIR EDUCATION AND LEARNING |
BASIT L. JAN |
| 14 |
[GO] |
2022―Mar―10 |
EARLY USE OF REMDESIVIR IN OBESE MALE PATIENTS WITH COVID-19 CAN IMPROVE THE PROGNOSIS |
CRISTINA POPESCU |
| 15 |
[GO] |
2022―Mar―10 |
SATISFACTION WITH THE PROFESSION OF PHARMACISTS, ESPECIALLY DURING THE 2019 CORONAVIRUS PANDEMIC |
WERONIKA GUZENDA |
| 16 |
[GO] |
2022―Mar―10 |
REAL-LIFE COMPARISON OF TOCILIZUMAB AND ANAKINRA ASSOCIATED WITH CORTICOSTEROID USE IN A COHORT OF HOSPITALIZED PATIENTS WITH SARS-CoV-2 INFECTION |
LAURENȚIU MIHĂIȚĂ STRATAN |
| 17 |
[GO] |
2022―Feb―02 |
OXIDATIVE STRESS AND CYTOKINES’ INVOLVEMENT IN THE OCCURENCE AND PROGRESSION OF DIABETIC COMPLICATIONS IN THE COVID-19 PANDEMIC CONTEXT |
MARIANA CORNELIA TILINCA |
| 18 |
[GO] |
2022―Feb―02 |
THE ROLE OF HMGB1 IN THE IMMUNE RESPONSE TO SARS-COV-2 INFECTION: FROM PATHOGENESIS TOWARDS A NEW POTENTIAL THERAPEUTIC TARGET |
MUHAMMAD TOREQUL ISLAM |
| 19 |
[GO] |
2022―Jan―20 |
POSSIBLE MUTATION PATHWAYS IN SARS-CoV-2 |
MUHAMMAD TOREQUL ISLAM |
| 20 |
[GO] |
2021―May―06 |
KEY POINTS IN FERTILITY PRESERVATION TREATMENT STRATEGIES DURING COVID-19 PANDEMIC. AN UPDATE ON PHARMACOLOGICAL THERAPIES |
VALENTIN NICOLAE VARLAS |
| 21 |
[GO] |
2021―Mar―01 |
THE IMPACT OF COVID-19 LOCKDOWN ON THE LIFESTYLE AND DIETARY PATTERNS AMONG ROMANIAN POPULATION |
MAGDALENA MITITELU |
| 22 |
[GO] |
2021―Jan―14 |
HIGH SKIN MELANIN CONTENT, VITAMIN D DEFICIENCY AND IMMUNITY: POTENTIAL INTERFERENCE FOR SEVERITY OF COVID-19 |
MUHAMMAD TOREQUL ISLAM |
| 23 |
[GO] |
2021―Jan―14 |
NITRIC OXIDE PATHWAY AS A POTENTIAL THERAPEUTIC TARGET IN COVID-19 |
KHALID M. ALKHARFY |
| 24 |
[GO] |
2021―Jan―14 |
STUDY OF AVAILABLE ANTIVIRAL TREATMENTS FOR COVID-19 DURING PREGNANCY |
OCTAVIAN GABRIEL OLARU |
| 25 |
[GO] |
2020―Nov―05 |
LYSOSOMOTROPIC PROPERTIES OF SODIUM BICARBONATE AND COVID-19 |
MUDASIR MIR |
| 26 |
[GO] |
2020―Nov―05 |
INFLUENCE OF TOCILIZUMAB ON THE OUTCOME OF PATIENTS WITH COVID-19. RETROSPECTIVE OBSERVATIONAL STUDY |
EUGENIA IRENE DAVIDESCU |
| 27 |
[GO] |
2020―Nov―05 |
NON-ALCOHOLIC FATTY LIVER DISEASE IN DIABETIC PATIENTS AS RISK FACTOR FOR POOR PROGNOSIS OF COVID-19: AN UPDATE OF POTENTIAL MECHANISMS AND TREATMENT CONSIDERATIONS |
OVIDIU PAUL CALAPOD |
| 28 |
[GO] |
2020―Aug―03 |
A FOLLOW-UP STUDY OF THE OCCUPATIONAL HAND ECZEMA AND SKIN DAMAGE RISK IN HEALTHCARE PROVIDERS FROM ROMANIA IN TIME OF COVID-19 |
ANCA E. CHIRIAC |
| 29 |
[GO] |
2020―Aug―03 |
TREATMENT WITH HYDROXYCHLOROQUINE IN PATIENTS WITH COVID-19. EXPERIENCE OF A NEUROLOGY DEPARTMENT |
EUGENIA IRENE DAVIDESCU |
| 30 |
[GO] |
2020―Aug―03 |
ASSERTION FOR MONTELUKAST IN THE COVID-19 PANDEMICS? |
ANDRA IULIA SUCEVEANU |
| 31 |
[GO] |
2020―Jun―29 |
HYDROXYCHLOROQUINE AND AZITHROMYCIN COMBINATION COULD BE LETHAL TO COVID-19 PATIENTS |
FIRDOUS SAYEED MOHAMMAD |
| 32 |
[GO] |
2020―Jun―29 |
DIABETES AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM: IMPLICATIONS FOR COVID-19 PATIENTS WITH DIABETES TREATMENT MANAGEMENT |
DOINA CATRINOIU |
| 33 |
[GO] |
2020―Apr―29 |
A NEW ERA FOR THE THERAPEUTIC MANAGEMENT OF THE ONGOING COVID-19 PANDEMIC |
ANDREEA LETIȚIA ARSENE |
